The researchers argue that the integration of explainable AI into clinical decision-making pipelines could reshape cancer ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Importantly, stomach cancer is also being diagnosed in an increasing number of younger people -- that is, those younger than 50. In 2019, these cancers -- also called early-onset -- accounted for ...

For many, the end of cancer treatment feels like crossing a finish line. Chemotherapy is done, scans are clear, and follow-up ...

Standard cancer screenings in the U.S. overlook nearly 70% of cancers and cancer subtypes. Multiple-cancer early detection (MCED) blood tests can help identify cancer biomarkers for multiple cancer ...

A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

The Galleri test aims to find fragments of DNA in a person’s blood that can indicate the presence of a cancerous tumor.

Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s ...

Grail announced fresh data on Friday from a large U.S. study of its flagship Galleri blood-based test for detecting dozens of ...

Teal Health is the first federally approved at-home cervical cancer screening. The Food and Drug Administration approved the ...